Pegasus Tech Ventures and CYBERDYNE Launch 10 Billion Japanese Yen Corporate Venture Capital Fund to Accelerate “HCPS Cybernics with Physical AI”
Pegasus Tech Ventures and CYBERDYNE Launch 10 Billion Japanese Yen Corporate Venture Capital Fund to Accelerate “HCPS Cybernics with Physical AI”
SAN JOSE, Calif.--(BUSINESS WIRE)--Pegasus Tech Ventures, a Silicon Valley–based global venture capital firm and leading provider of Venture Capital-as-a-Service (VCaaS) solutions, today announced the launch of a JPY 10 billion (US $60M) Corporate Venture Capital (CVC) fund in partnership with CYBERDYNE, Inc., a leading company in the field of Cybernics that fuses bio/medical systems with AI-robotics and information technologies.
Robotics and intelligent systems are becoming increasingly important in addressing some of the world’s most pressing challenges.
Share
Pegasus Tech Ventures will serve as the General Partner of the fund, and CYBERDYNE will participate as the sole Limited Partner. Through Pegasus’ VCaaS platform, CYBERDYNE will gain access to Silicon Valley and leading innovation ecosystems around the world. Leveraging Pegasus’ global network of startups, investors, and corporate partners, the collaboration is designed to accelerate strategic investments, technology partnerships, and new business opportunities in emerging sectors.
The fund will invest in startups developing technologies across robotics, Physical AI, healthcare, automation, and intelligent systems, with a particular focus on advancing CYBERDYNE’s vision for HCPS Cybernics with Physical AI, fusing humans, AI-robotics and information systems across the Human-Cyber-Physical Space (HCPS).
Founded in 2004 by Professor Yoshiyuki Sankai of the University of Tsukuba, CYBERDYNE is a pioneer in Cybernics. The company’s flagship product, a world-first wearable cyborg device, HAL®, is designed to assist, enhance, improve and regenerate human physical functions by detecting and responding to bioelectric signals from the wearer. HAL® has been widely adopted in Japan and overseas across a broad range of applications, particularly in the medical and healthcare sectors.
Through the partnership, CYBERDYNE aims to accelerate technology development, business creation, and global expansion opportunities by collaborating with startups and innovation ecosystems worldwide while addressing societal challenges such as aging populations, workforce shortages, and increasing healthcare demands.
For more than a decade, Pegasus has served as a gateway connecting corporations across Asia with Silicon Valley and the broader global innovation ecosystem. Through its VCaaS platform, Pegasus provides corporate partners with access to venture investing, startups, and strategic relationships with some of the world’s most promising technology companies.
“CYBERDYNE is committed to advancing HCPS Cybernics with Physical AI and creating new value by fusing humans, AI-robotics and information systems,” said Professor Yoshiyuki Sankai, Founder & CEO of CYBERDYNE. “By partnering with Pegasus Tech Ventures and leveraging its global innovation network, we look forward to accelerating technology development, business co-creation, and global expansion opportunities.”
“Robotics and intelligent systems are becoming increasingly important in addressing some of the world’s most pressing challenges,” said Dr. Anis Uzzaman, Founder & CEO of Pegasus Tech Ventures. “Through our Venture Capital-as-a-Service platform, we look forward to connecting CYBERDYNE with leading entrepreneurs, breakthrough technologies, and strategic opportunities from Silicon Valley and innovation ecosystems that align with their long-term vision.”
About CYBERDYNE, Inc.
CYBERDYNE is a Japanese technology company founded in 2004 by Professor Yoshiyuki Sankai of the University of Tsukuba. To address complex and structural societal challenges such as population aging, the company advances HCPS Cybernics with Physical AI as its core technology, fusing bio/medical systems with AI-robotics and information systems. Based on this core technology, CYBERDYNE promotes two complementary business initiatives: “Cybernics Medical and Healthcare Innovation,” which connects hospitals, homes, and workplaces through AI-driven analysis, diagnosis, treatment, and data integration; and “Cybernics Life Innovation,” which applies AI-enabled control and assistance technologies to support human mobility, logistics, and work activities in everyday living and working environments. For more information, please visit www.cyberdyne.jp/english/
About Pegasus Tech Ventures
Pegasus Tech Ventures is a global venture capital firm and leading provider of Venture Capital-as-a-Service (VCaaS) solutions. The firm partners with corporations worldwide to help them access emerging technologies, invest in innovative startups, and accelerate open innovation initiatives through its global network spanning Silicon Valley, Asia, Europe, and other leading innovation ecosystems. Pegasus manages over 40 funds and over USD $2B in assets, and has invested in more than 300 startups globally, including SpaceX, OpenAI, Anthropic, Airbnb, Coinbase, and X (formerly Twitter). Through its venture platform and corporate venture management services, Pegasus serves as a bridge between corporations and the next generation of technology companies. For more information, please visit www.pegasustechventures.com
Contacts
Media Contact
Diana Kandah
Marketing Director
Pegasus Tech Ventures
kandah@pegasusventures.com
408-645-5532
